MedPath

Prediction of Risk Factors for Adverse Events After Head and Neck Vascular Recanalization Surgery Based on Machine Learning Models

Completed
Conditions
Machine Learning
Registration Number
NCT06120478
Lead Sponsor
Tang-Du Hospital
Brief Summary

Prediction of risk factors for adverse events after head and neck vascular recanalization surgery based on machine learning models

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1300
Inclusion Criteria
  • All enrolled patients were diagnosed with clear head and neck artery stenosis and a risk event after head and neck revascularization;
  • Location of lesion: origin of internal carotid artery, bifurcation of internal and external carotid arteries;
  • Patients with symptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, and with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 50% found on angiography;
  • Asymptomatic head and neck artery stenosis and risk events after head and neck revascularization, with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 60% found on angiography;
  • Asymptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, with a non-invasive examination of stenosis degree less than 70%, but angiography or other examinations indicate that the stenosis lesion is in an unstable state;
  • Symptomatic head and neck artery stenosis and risk events after head and neck revascularization, non-invasive examination of head and neck artery stenosis and risk events after head and neck revascularization are 50% to 69%;
  • Sign the project informed consent form
Exclusion Criteria
  • Patients with poor overall condition and intolerance to general anesthesia;
  • Patients with mental illness or severe mental illness;
  • Severe respiratory system diseases;
  • Pregnant and lactating women;
  • Participating in another clinical study;
  • Patients with advanced tumors or those who are expected to die within one year;

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
deathone year
Secondary Outcome Measures
NameTimeMethod
Recurrence of strokeone year

Trial Locations

Locations (1)

Tangdu Hospital

🇨🇳

Xi'an, Shaanxi, China

Tangdu Hospital
🇨🇳Xi'an, Shaanxi, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.